Singapore markets closed

PMV Pharmaceuticals, Inc. (PMVP)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.1300-0.0800 (-3.62%)
At close: 04:00PM EDT
2.1300 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
53,998
55,885
51,988
36,493
23,933
-
Selling general and administrative
22,875
24,247
25,052
21,800
11,009
-
Total operating expenses
76,873
80,132
77,040
58,293
34,942
-
Operating income or loss
-76,873
-80,132
-77,040
-58,293
-34,942
-
Total other income/expenses net
-25
3
87
21
-143
-
Income before tax
-65,100
-68,958
-73,326
-57,823
-34,434
-
Income tax expense
2
2
-9
23
6
-
Income from continuing operations
-65,102
-68,960
-73,317
-57,846
-34,440
-
Net income
-65,102
-68,960
-73,317
-57,846
-34,440
-
Net income available to common shareholders
-65,102
-68,960
-73,317
-57,846
-34,440
-
Basic EPS
-1.56
-
-1.61
-1.28
-2.40
-0.81
Diluted EPS
-1.56
-
-1.61
-1.28
-2.40
-0.81
Basic average shares
46,595
-
45,595
45,138
14,364
31,234
Diluted average shares
46,595
-
45,595
45,138
14,364
31,234